Particle.news

Study Proposes Allergies Begin With Energy Failure in Barrier Cells

If borne out, the idea would shift research and prevention toward restoring epithelial cell energy as an upstream target for allergy control.

Overview

  • The paper, published in the journal Allergy on Oct. 29 and summarized in a Nov. 20 press release, presents an 'outside‑in' bioenergetic hypothesis that many allergic diseases may start with mitochondrial dysfunction in epithelial barrier cells.
  • The strongest and most consistent signal was in eosinophilic oesophagitis, where genes that clear damaged mitochondria were reduced across 13 independent patient cohorts.
  • The mitochondrial or barrier‑cell signal was uneven across conditions: it was only partly present in hay fever and was not detected in established asthma or nasal polyps.
  • The claim is based on a large multi‑omic reanalysis covering 116 case‑control cohorts and about 3,776 patients with co‑authors from institutions in Australia, the US, Europe and Asia.
  • Authors stress this is a testable hypothesis that needs prospective studies—for example sampling infants’ barrier cells before disease onset—and say validation could reorient prevention and therapies upstream of the immune response.